The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. Genetics and Molecular Research, [S. l.], v. 25, n. 1, p. 1–25, 2026. DOI: 10.4238/1fvw5h08. Disponível em: https://geneticsmr.com/index.php/gmr/article/view/205.. Acesso em: 29 jan. 2026.